Lipoproteins and angiotensin II exert synergistic effects on signalling processes in vascular smooth muscle cells.
Resink
T J
TJ
Department of Research, Basel University Hospital, Switzerland.
Bochkov
V N
VN
Tkachuk
V A
VA
Bühler
F R
FR
Hahn
A W
AW
D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D002478:Cells, Cultured; D004357:Drug Synergism; D006801:Humans; D007295:Inositol Phosphates / Q000096:biosynthesis; D008075:Lipoproteins, HDL / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D008077:Lipoproteins, LDL / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
D007295:Inositol Phosphates; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D000804:Angiotensin II